Anne A. Finucane - 16 May 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: Director
Signature: /s/ Anne M. Finucane
Issuer symbol: CVS
Transactions as of: 16 May 2024
Net transactions value: +$125,625
Form type: 4
Filing time: 17 May 2024, 17:38:46 UTC
Previous filing: 01 May 2024
Next filing: 30 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CVS	Common Stock						7,232	16 May 2024	Direct
holding	CVS	Common Stock						25,198	16 May 2024	By Finucane Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Share Credits	Award	$125,625	+2,184	+29%	$57.52	9,748	16 May 2024	Common Stock	2,184	$0.000000	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.
F2	Consists of deferred stock compensation payable pursuant to Reporting Person's election.